Vanguard Personalized Indexing Management LLC Acquires 9,436 Shares of Stryker Corporation $SYK

Key Points

• Vanguard Personalized Indexing Management LLC increased its holdings in Stryker Corporation by 21.7%, acquiring an additional 9,436 shares, bringing their total to 52,869 shares valued at approximately $20.9 million.
• Insider transactions include significant sales by Director Ronda E. Stryker, who sold 200,000 shares for $75.29 million, reducing their ownership by 5.84%.
• Stryker recently announced a quarterly dividend of $0.84 per share, translating to an annual yield of 0.9%, with a payout ratio of 44.50%.

Vanguard Personalized Indexing Management LLC increased its position in shares of Stryker Corporation (NYSE:SYK - Free Report) by 21.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 52,869 shares of the medical technology company's stock after purchasing an additional 9,436 shares during the period. Vanguard Personalized Indexing Management LLC's holdings in Stryker were worth $20,918,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. Brighton Jones LLC boosted its position in Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company's stock valued at $1,643,000 after buying an additional 609 shares during the period. GAMMA Investing LLC boosted its position in Stryker by 16.4% in the 1st quarter. GAMMA Investing LLC now owns 5,574 shares of the medical technology company's stock valued at $2,075,000 after buying an additional 785 shares during the period. Assenagon Asset Management S.A. boosted its position in Stryker by 1.1% in the 1st quarter. Assenagon Asset Management S.A. now owns 10,375 shares of the medical technology company's stock valued at $3,862,000 after buying an additional 110 shares during the period. Focus Financial Network Inc. purchased a new stake in Stryker in the 1st quarter valued at about $214,000. Finally, Fort Washington Investment Advisors Inc. OH lifted its position in shares of Stryker by 4.3% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 5,710 shares of the medical technology company's stock worth $2,126,000 after purchasing an additional 234 shares during the period. 77.09% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Stryker

In other Stryker news, insider Viju Menon sold 500 shares of Stryker stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the transaction, the insider directly owned 12,511 shares of the company's stock, valued at $4,886,921.71. The trade was a 3.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the transaction, the director directly owned 3,222,108 shares in the company, valued at $1,212,962,556.60. This trade represents a 5.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.90% of the stock is owned by insiders.

Analyst Ratings Changes

SYK has been the subject of several research reports. Redburn Partners set a $420.00 price objective on shares of Stryker in a research note on Thursday, September 18th. Rothschild & Co Redburn initiated coverage on shares of Stryker in a research note on Thursday, September 18th. They set a "neutral" rating and a $420.00 price objective for the company. Wells Fargo & Company boosted their price objective on shares of Stryker from $435.00 to $445.00 and gave the stock an "overweight" rating in a research note on Friday, August 1st. BTIG Research reaffirmed a "buy" rating on shares of Stryker in a report on Monday, July 14th. Finally, Rothschild Redb raised shares of Stryker to a "hold" rating in a report on Thursday, September 18th. Fifteen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $430.10.

Stryker Stock Performance

SYK opened at $364.77 on Friday. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. The company has a market cap of $139.46 billion, a price-to-earnings ratio of 48.31, a PEG ratio of 2.63 and a beta of 0.94. Stryker Corporation has a 52-week low of $329.16 and a 52-week high of $406.19. The firm's fifty day simple moving average is $380.25 and its two-hundred day simple moving average is $378.83.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, topping the consensus estimate of $3.07 by $0.06. The firm had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The company's revenue for the quarter was up 11.1% on a year-over-year basis. During the same period last year, the firm posted $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. Equities analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.9%. Stryker's payout ratio is 44.50%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.